AuTologous Wound Therapy, Inc. Announces Name Change to Cytomedix, Inc.

Business Editors/Health & Medical Writers

LITTLE ROCK, Ark.--(BUSINESS WIRE)--April 4, 2000

AuTologous Wound Therapy, Inc. (OTC:AWTX) ("AWTX") has changed its name.

The company filed an amendment of its certificate of incorporation with the Delaware Secretary of State, adopting the new name of "Cytomedix, Inc." effective March 30, 2000. Shareholders holding more than the ownership interests required to approve the name change did so by a consent action in lieu of a meeting dated March 29, 2000.

In connection with the name change, the ticker symbol for the company's stock will be changed and the new symbol will be announced shortly.

The decision to change the name to Cytomedix more accurately reflects management's intention to pursue a broader range of opportunities in cellular therapy and molecular biotechnology markets, beyond the company's existing activities in autologous treatments for non-healing diabetic neuropathies, and venous stasis and decubitus ulcers.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Cytomedix, Inc. (the "Company"), or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements.

Readers of this press release may obtain additional information on the Company in reports and other information filed in accordance with the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Such reports and other information filed by the Company can be inspected and copied at the public reference facilities maintained by the Commission at the Public Reference Room, 450 Fifth Street, N.W., Washington, DC 20549.

Copies of such material can also be obtained a prescribed rates from the Public Reference Section of the Commission, Washington, DC 20549 or by calling the Commission at 1-800-SEC-0330.

In addition, Registration Statements and other filings made with the Commission through its Electronic Data Gathering Analysis and Retrieval System ("EDGAR") and publicly available through the Commission's website located at http://www.sec.gov.